Cargando…

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Detalles Bibliográficos
Autores principales:	Kinoshita, Makoto, Yokote, Koutaro, Arai, Hidenori, Iida, Mami, Ishigaki, Yasushi, Ishibashi, Shun, Umemoto, Seiji, Egusa, Genshi, Ohmura, Hirotoshi, Okamura, Tomonori, Kihara, Shinji, Koba, Shinji, Saito, Isao, Shoji, Tetsuo, Daida, Hiroyuki, Tsukamoto, Kazuhisa, Deguchi, Juno, Dohi, Seitaro, Dobashi, Kazushige, Hamaguchi, Hirotoshi, Hara, Masumi, Hiro, Takafumi, Biro, Sadatoshi, Fujioka, Yoshio, Maruyama, Chizuko, Miyamoto, Yoshihiro, Murakami, Yoshitaka, Yokode, Masayuki, Yoshida, Hiroshi, Rakugi, Hiromi, Wakatsuki, Akihiko, Yamashita, Shizuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2018
Materias:	Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143773/ https://www.ncbi.nlm.nih.gov/pubmed/30135334 http://dx.doi.org/10.5551/jat.GL2017

Ejemplares similares

Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

Jas. G. Lyon
Publicado: (1883)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

A Conversation with Jas Pal Badyal
por: Patel, Prachi
Publicado: (2018)

Mycoremediation of Endosulfan and Its Metabolites in Aqueous Medium and Soil by Botryosphaeria laricina JAS6 and Aspergillus tamarii JAS9
por: Silambarasan, Sivagnanam, et al.
Publicado: (2013)

Impact of sitagliptin combination therapy and hypoglycemia in Japanese patients with type 2 diabetes: a multi-center retrospective observational cohort study
por: Saito, Tomoyuki, et al.
Publicado: (2020)

Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque
por: Egusa, Genshi
Publicado: (2021)

Extracts from Medical Clinic of Prof. Jas. T. Whittaker
Publicado: (1883)

Prof. Jas. B. McCaw, M. D.
Publicado: (1858)

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Guidance for Pediatric Familial Hypercholesterolemia 2017
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

WIRED 4 - A generic Event Display plugin for JAS 3
por: Dönszelmann, M
Publicado: (2005)

Interactive Data Analysis on the Grid using Globus 3 and JAS3
por: Johnson, T, et al.
Publicado: (2005)

Contribution of Remnant Cholesterol to Coronary Atherosclerosis
por: Ohmura, Hirotoshi
Publicado: (2022)

The Late Dr. Marshall H. Webb: Reply to Dr. Jas W. White
por: Osmond, E.
Publicado: (1883)

Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project
por: Ohmura, Hirotoshi, et al.
Publicado: (2019)

Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes
por: Ohmura, Hirotoshi, et al.
Publicado: (2015)

Progression of Carotid Atherosclerosis in Two Japanese Populations with Different Lifestyles
por: Kubota, Mitsunobu, et al.
Publicado: (2017)

Westernization of Lifestyle and Atherosclerosis in the Japanese: Lessons from the Hawaii – Los Angeles – Hiroshima Study
por: Yoneda, Masayasu, et al.
Publicado: (2021)

A 13-LOX participates in the biosynthesis of JAs and is related to the accumulation of baicalein and wogonin in Scutellaria baicalensis
por: Geng, Dali, et al.
Publicado: (2023)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
por: Arai, Hidenori, et al.
Publicado: (2018)

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
por: Yokote, Koutaro, et al.
Publicado: (2019)

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia
por: Yamashita, Shizuya, et al.
Publicado: (2020)

SUN-020 Analyses Of Clock Gene Expressions In Peripheral Leukocytes In Hypercortisolism
por: Ishiwata, Kazuki, et al.
Publicado: (2019)

Percutaneous transhepatic coil and cover technique with small system for the extrahepatic portal vein hemorrhage after pancreaticoduodenectomy
por: Ono, Shigeshi, et al.
Publicado: (2022)

Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice
por: Kobuke, Kazuhiro, et al.
Publicado: (2015)

Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance
por: Matsuba, Ikuro, et al.
Publicado: (2018)

Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination
por: Yamashita, Shizuya, et al.
Publicado: (2019)

Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate
por: Yamashita, Shizuya, et al.
Publicado: (2021)

Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double‐blind placebo‐controlled clinical trials
por: Yokote, Koutaro, et al.
Publicado: (2021)

Primary Squamous Cell Lung Cancer With Frequent Episodes of Sustained Ventricular Tachycardia due to Myocardial Metastasis
por: Toyoshi, Sayaka, et al.
Publicado: (2023)

Correlation between Renal Function and Common Risk Factors for Chronic Kidney Disease in a Healthy Middle-Aged Population: A Prospective Observational 2-Year Study
por: Ohno, Michiya, et al.
Publicado: (2014)

Are Patients with Low Non-HDL Cholesterol “Non-responders” to Statin Therapy on Coronary Plaque Regression?
por: Koba, Shinji
Publicado: (2016)

Physical Fitness and Development of High Non-High-Density Lipoprotein Cholesterol
por: Koba, Shinji
Publicado: (2018)

Noncholesterol Sterols and Sitosterolemia in Clinical Practice
por: Koba, Shinji
Publicado: (2020)

An exopolysaccharide-producing novel Agrobacterium pusense strain JAS1 isolated from snake plant enhances plant growth and soil water retention
por: Kaur, Jaspreet, et al.
Publicado: (2022)

Diagnosis and Management of Sitosterolemia 2021
por: Tada, Hayato, et al.
Publicado: (2021)

Is obesity an absolute evil? Increase in adipose tissue does not always decrease insulin sensitivity
por: Ishikawa, Ko, et al.
Publicado: (2014)

Time to consider an Asian guideline for management of dyslipidemia?
por: Yokote, Koutaro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4213iiohq8sdmrbqc6fku0gidn